MedTrace Logo

Pilot Study on a Dietary Supplement With EndoGen™ as Adjunct Therapy in Women With Endometriosis

NCT07228975 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 36

Last updated 2025-11-20

No results posted yet for this study

Summary

Current treatments for endometriosis, such as NSAIDs and hormone therapies, are meant for long-term use but often cause side effects, including stomach, liver, heart, and kidney issues; allergies; and hormonal problems like weight gain, acne, and bone loss. Therefore, one option being studied is a food supplement based on parsley extract (Petroselinum crispum), rosemary extract (Rosmarinus Officinalis L.), and selenium, combined with mountain celery and Vitamins B6, D, and E. The study's goal is to show improvement in pain and reduced use of NSAIDs in fertile women with endometriosis.

Conditions

  • Endometriosis

Interventions

DIETARY_SUPPLEMENT

MetrioFen Gocce

Solution-20 drops per day (equal to about 1 ml) on an empty stomach.

Sponsors & Collaborators

  • Hippocrates Research

    collaborator OTHER

  • Endok s.r.l.

    lead INDUSTRY

Principal Investigators

  • Gianluigi Corsetti, CEO · ENDOK S.R.L. - Via di Valle Alessandra, 53, Rome (RM) - Italy

  • Luciano Serra, Chief Scientific Officer · ENDOK S.R.L. - Via di Valle Alessandra, 53, Rome (RM) - Italy

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-09-09
Primary Completion
2025-07-31
Completion
2025-07-31

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07228975 on ClinicalTrials.gov